Friday 6 November 2026 Export BBNX’s income statement to Excel — free account

Beta Bionics, Inc.

BBNX Healthcare Medical Devices

Beta Bionics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $100.3 million, up 53.9% from fiscal 2024.

Revenue: +30.3%
EPS: −58.6%
Free cash flow: −45.5%

Quarter to September 2026, against a year earlier

15.72 0.23 +1.48%

Follow BBNX

Alert me

Market cap: $842.1M
P/E: 0.0×
Fwd P/E: −8.2×
Dividend yield: —
F-score: 5/9
Altman Z: 16.89
Beneish M: −1.86
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	(346.51%)	(22.71%)	(26.16%)	(23.88%)
ROA Full definition →		(30.60%)	(20.68%)	(23.45%)	(21.48%)
ROIC Full definition →		(65.51%)	(67.46%)	(68.47%)	(35.92%)
Return on Tangible Assets Full definition →		(29.81%)	(28.28%)	(33.82%)	(30.57%)
Average Days of Receivables Full definition →		62.32	52.15	55.37	59.27
Free Cash Flow per Share Full definition →		(8.22)	(7.60)	(7.59)	(7.36)
Free Cash Flow Full definition →		(332.96)	(337.86)	(338.15)	(342.70)
Capital Expenditures Full definition →		(282.03)	(283.08)	(282.34)	(283.33)
Other line items
Cash ROIC Full definition →		(65.69%)	(71.75%)	(77.39%)	(53.41%)
Accounts Receivable Turnover Full definition →		6.89	8.89	8.08	7.90
Accounts Payable Turnover Full definition →		11.39	16.37	11.31	11.52
Inventory Turnover Full definition →		2.55	2.39	2.41	2.43
Average Days of Payables Full definition →		40.80	17.91	39.37	32.46
Days of Inventory on Hand Full definition →		177.32	183.35	175.97	159.25
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		34.70%	34.07%	32.70%	33.55%
Selling, General and Administrative Expense of Revenue Full definition →		92.20%	93.21%	95.36%	97.82%
Share Based Compensation of Revenue Full definition →		16.34%	17.22%	17.82%	18.42%
Operating CF/Net income Full definition →		0.70	0.82	0.76	0.71
Depreciation/Fixed assets Full definition →		0.33	0.32	0.52	0.56
Capex/Depreciation Full definition →		(98.10)	(86.89)	(50.11)	(42.90)
Revenue per Share Full definition →		2.47	2.48	2.67	2.73
Operating CF per Share Full definition →		(1.26)	(1.23)	(1.25)	(1.28)
Capex per Share Full definition →		(6.96)	(6.37)	(6.34)	(6.09)
Capex to Sales Full definition →		2.81	2.57	2.37	2.23

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly